Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2000-10-17
pubmed:abstractText
The surveillance study was conducted to determine the antimicrobial activity of fluoroquinolones (ofloxacin, levofloxacin, ciprofloxacin, tosufloxacin) and other 20 antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. The resistance to fluoroquinolones was remarkable in Enterococci, methicillin-resistant staphylococci and Pseudomonas aeruginosa from UTI. However, many of the common pathogens such as Streptococcus pneumoniae including penicillin-resistant isolates, methicillin-susceptible Stahylococcus aureus, Moraxella catarrhalis, the family of Enterobacteriaceae, Haemophilus influenzae including ampicillin-resistant isolates have been kept to be susceptible to fluoroquinolones. About 90% of P. aeruginosa isolates from RTI were susceptible to fluoroquinolones. In conclusion, the results from this surveillance study suggest that fluoroquinolones are useful in the treatment of various bacterial infections including respiratory infections.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0368-2781
pubmed:author
pubmed-author:FunatoTT, pubmed-author:HongoTT, pubmed-author:IgariJJ, pubmed-author:IinumaYY, pubmed-author:IshigoSS, pubmed-author:IshiiKK, pubmed-author:IshiiMM, pubmed-author:ItorII, pubmed-author:IwataMM, pubmed-author:KaimoriMM, pubmed-author:KakuMM, pubmed-author:KamihiraSS, pubmed-author:KandaMM, pubmed-author:KashitaniFF, pubmed-author:KatohJJ, pubmed-author:KawaharaSS, pubmed-author:KawamuraCC, pubmed-author:KudohMM, pubmed-author:KuwabaraMM, pubmed-author:MatsudouYY, pubmed-author:MatsushimaTT, pubmed-author:MiyashitaNN, pubmed-author:MiyazakiSS, pubmed-author:MiyazakiYY, pubmed-author:MurakamiNN, pubmed-author:NakagawaKK, pubmed-author:NakasoneII, pubmed-author:NegayamaKK, pubmed-author:NikiYY, pubmed-author:NisawatairaTT, pubmed-author:OguriTT, pubmed-author:OkadaJJ, pubmed-author:OnoJJ, pubmed-author:SaitoYY, pubmed-author:SatoNN, pubmed-author:TairaMM, pubmed-author:TakadaTT, pubmed-author:TakiiMM, pubmed-author:TamakiII, pubmed-author:TashiroHH, pubmed-author:TazawaYY, pubmed-author:ToyoshimaSS, pubmed-author:TsujioYY, pubmed-author:UeharaNN, pubmed-author:UenoKK, pubmed-author:WatanabeNN, pubmed-author:YamaguchiKK, pubmed-author:YamanakaKK, pubmed-author:YasujimaMM, pubmed-author:YoshidaTT
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
387-408
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
[Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].
pubmed:affiliation
Department of Microbiology, Toho University School of Medicine.
pubmed:publicationType
Journal Article, English Abstract